Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

AD/PD 2023

Browse Popular Uploads...

View all
4:51
European task force recommendations: shifting memory clinics towards prevention
Giovanni Frisoni • 30 Mar 2023
2:34
Assessing clinical meaningfulness with ‘time saved’ in Alzheimer’s disease
Suzanne Hendrix • 21 Mar 2023
2:48
TRAILBLAZER-ALZ 4: direct comparison of donanemab and aducanumab
Stephen Salloway • 19 Apr 2023
3:23
How does TPS work in Alzheimer’s disease?
Lars Wojtecki • 23 Mar 2023

Biomarker Breakthroughs

View all
2:10
Streamlining dementia diagnosis with digital biomarkers
M. Florencia Iulita • 28 Mar 2023
2:44
CSF synaptic markers in Alzheimer’s disease
Andrea Pilotto • 23 Mar 2023
4:41
Decreased kidney function associated with increased plasma p-tau levels
Bruna Bellaver • 24 Mar 2023
2:39
Detecting retinal Aβ: a promising path for non-invasive Alzheimer’s disease diagnosis
Mourad Tayebi • 30 Mar 2023

Novel Treatment Updates

View all
4:23
Phase II trial of AR1001 as a potential treatment for Alzheimer’s disease
David Greeley • 28 Mar 2023
1:50
Safety results of the Phase III gantenerumab GRADUATE I and II studies
Stephen Salloway • 19 Apr 2023
4:51
Improving the next generation of anti-amyloid antibodies: prioritizing selectivity with PMN310
Johanne Kaplan • 30 Mar 2023
7:55
All-in-one AAV vector for epigenome editing shows efficient APOE downregulation in vivo
Boris Kantor • 15 Mar 2023
The content of VJDementia is intended for healthcare professionals